Member Info for HereforHemo

If memory serves didn’t he add ‘don’t worry about the timescales’? At the time I thought that meant it will happen when it happens but having looked into the FDA application process I now believe he meant that it will happen sooner than most realise. Still a little ****ed off that we have to find this stuff out ourselves but I suppose that’s the price we pay for having a genius scientist who has only one focus, and that’s getting his product candidates into clinical trials.

May I suggest anyone in contact with them to ask Vlad to post on the HEMOGENYX website that they are indeed using this new method. Thx in advance.

Mr India I have to agree with you, their communication is appalling!

After reading the comment yesterday that Hemogenyx hadn’t met with the FDA yet, despite the FDA guidelines stating it would be within 60 days of application, I thought I’d explore their website to see if I could establish if anything has changed in their approach, and why the meeting hadn’t taken place yet.
I think I may have found the reason why! The FDA appears to have changed their PIND and IND application process such that a meeting is no longer necessary. It seems they have set up a new secure online process to replace meetings called the CDER next generation portal, which is accessed through an electronic submissions gateway. This will not only store all data securely in one place but will aid in getting applications approved in a more timely manner. I’m of the belief that Hemogenyx might be one of the first companies to be using this process. I don’t think they’ll be meeting at all with the FDA but believe their application will move forward faster as a result.

Are we about to announce something special? You never know with Vlad lol.

https://twitter.com/vmsandler/status/1491830122676109319?s=21

Dhub I don’t know why you would be concerned. If there was negative FDA feedback or delays to the CAR-T schedule then maybe yes, but as far as I’m concerned Hemogenyx appear very confident on their product candidate. I’d be quite happy with the next RNS being a fast track IND application, that’s what I expect anyway. As I’ve said, I’m very bullish about the future. As always just my personal opinion.

So let’s try to figure out where we are. Hemogenyx advertising for someone with manufacturing experience to manufacture CAR-T which by chance coincides with them moving into a high tech laboratory where they will have the capability to manufacture their own CAR. And people are wondering whether the pre IND meeting with the FDA went well. Really?? If everything is getting lined up for clinical trials at the beginning of April, I’d say there’s a fair possibility that the IND application will be submitted this month with a 30 day approval that they must be pretty sure they’ll get. Unless the new employee is just going to sit there making coffee lol. Personally I’m more confident than ever. HEMO will become a clinical company in the very near future. Exciting times!

Our little gang of traders have only been able to play their games on low volume. As momentum builds along with volume in the run up to news it’s game over for them. Hope they enjoy their pub meal of their profit today. Bye bye. :)

A nice 15% rise would make them look as stupid as they actually are. Come on HEMO!

Volume and buying pressure increasing so let’s hope it outweighs our little gang of traders, enough to lock them out. All looking good for a very good couple of quarters imo.

Mr I As I’ve said before, you either believe that Hemogenyx are going from an R&D company or you don’t. If you do then you shouldn’t be worrying about the SP today or tomorrow. When they submit their IND application things will start to move, but Vlad ONLY focuses on the science and the benefits to patients, whether we like it or not. When he delivers on the science the SP will substantially rerate. Most people view that happening soon. But, if you don’t believe him or the company and don’t believe they are making scientific advances and don’t believe in their best in class collaborations, don’t hold or buy the share. If you or anyone base your purchases or sells on a couple of imbeciles on Twitter or indeed anyone but yourself, I have to say you deserve whatever outcome awaits. Just be patient and wait!

Just a guess but probably badger who posts on the other BB?

Mr I whilst I agree with you the fact of the matter is Hemogenyx are promoting CAR-T and Penn. Imo they are hardly likely to be doing that if they had been told HEMO CAR-T didn’t work. On the contrary I believe they have been given positive feedback from the FDA and are bullish that this is going into clinical trials. Obviously just my take on things.

HT I’ve no doubt you do. :)

Hemotruth Yes, fall for what? I’m entitled to an opinion, I said I expect news, my take, my guess, imo. Think the difference between Mr India, me and you is that two of us are holding and one is constantly trying to be subtle in his deramping in order to trade. Oh and I predicted (guessed) it would turn blue today..surprise :)

PG I mean they make themselves unable to talk to.

Yes on both counts.

I am and I think we’ll see the orders later today.

My understanding from speaking to people with contacts is they’re being ghosted. My reading of that is we’ll be getting news soon. On the SP being red, think orders are being filled and I expect a blue finish today and moving forward. Just my take on things.

Is it just me or do others think that HEMO have had their pre-IND meeting with the FDA? I just can’t see them putting out a tweet like this unless they were very confident CAR-T was going into clinical trials and the only way they could be that confident is if they had already had the meeting and had confirmation the FDA were happy for them to submit their IND application. If I’m right that could be submitted in the very near future. Fingers crossed I’m right!

https://twitter.com/hemogenyxpharma/status/1489582141302353920?s=21